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Abstract. A chemically induced, 20-methylcholanthrene, lymphoblastic sarcoma, in
DBA/1J mice was used to determine the histocompatibility of the tumor between the
DBA/1J and C57BL/GJ strains. Although 8 different histocompatibility sites exist
between the 2 strains, this work demonstrated that these 8 sites were transmitted
and expressed as a 5 unit discrete factor phenotypic variation. Fi x Fi hybrid ani-
mals were tested through the Fg generation and showed that only 5 linkage groups are
involved in the transmission of the various histocompatibility sites. Survivors of the
implanted F9 generation were used as progenitors for the Fi0 generation. Tumor take
frequencies with the Fi0 generation demonstrated that the inheritance of tumor
susceptibility behaved as a discrete function of a 5 unit inheritance factor.
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Numerous publications attest to the
many independent units which constitute
the mouse histocompatibility sites (Lie-
belt and Liebelt 1967; Lilly and Duran-
Reynals 1972; Kearney et at 1975; Pass-
more and Hansen 1975). These histo-
compatibility sites have been assigned to
linkage groups and have, in many in-
stances, been mapped (Snell and Stimp-
fling 1966; Green 1971; Altman and Ditt-
mer 1972). There exists a great deal of
difference between C57BL/6 and DBA/1 J
histocompatibility sites (Snell and Stimp-
fling 1966; Green 1971; Altman and Ditt-
mer 1972). The former has at least 8
histocompatibility sites not found in the
latter. DBA/1J has 7 histocompatibility
sites not found in the C57BL/6 strain.
Thus a two-directional allelic difference
of 15 histocompatibility factors, repre-
sented by at least 5 or more linkage
groups, exists between these 2 strains of
mice.
The C57BL/6 strain is resistant to
methylcholanthrene chemical carcinogen-
esis, whereas the DBA/1J is highly sus-
ceptible (Scholes 1969). By using an
established tumor (185 implant genera-
tions) from the DBA/1J strain, we de-
termined to what extent implanted tu-
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mor susceptibility was transmitted to the
C57BL/6 background. In addition, we
hoped to be able to determine if any
epigenetic mechanisms were readily de-
tectable by utilizing crosses between the
2 strains of mice, and between the re-
sulting hybrids.
MATERIALS AND METHODS
Experimental animals were sexually mature
male and female mice of the DBA/1 J and
C57BL/6J inbred strain maintained in our lab-
oratory. Mice were given food and water ad
libitum, and had a 12 hour dark, 12 hour light
regimen.
The tumor was maintained in the DBA/1J
strain in which it was originally induced. Im-
plants were done on the 10th or 11th day from
the preceding tumor passage. Tumor implant
passages 185 to 232 were used in this study.
Histological sections stained with hematoxylin
and eosin were done every fifth passage and
microscopic examinations revealed no morpho-
logical change in the tumor. The tumor has
maintained its same morphological appearance
throughout its entire history and apparently is
stable. The tumor has been coded RaVe, and
according to the nomenclature of Bessis it is a
lymphoblastic sarcoma type tumor (Bessis
1956).
Hybrids were developed according to the
system of Green (1966) using the isogenic strains
C57BL/6J and DBA/1J. It was hoped that
hybrids which would be allogenic (genetically
disparate) to the parental strains and congenic
(differ at a single locus) to each other, with re-
gard to tumor susceptibility, would ensue.
Hybrid Fi and F2 were bred before they were
used for tumor implants. Generations F3
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through F8 were not implanted. The F9 gen-
eration was implanted with tumors prior to
breeding and the survivors of the F9 generation
were then the progenitors for the F10 generation.
The breeding scheme involved the use of cross-
intercross and also cross-backcross (see fig. 1).
Chi square proability values were used for
statistical evaluation of the data.
C57BL/6J
BACKCROSS
Implant .5 04
Tumor - 18
DBA/1J
Implant - 2OO
Tumor - 2OO
Fo HYBRID
I m p l a n t - 5 8 3
T u m o r - 1 5 0
SURVIVORS
Fw HYBRID
Implant -S 0 9
Tumor • 5 5
FIGURE 1. Flow diagram showing the breeding
patterns followed to obtain mice for tumor im-
plant. Also shown is the number of animals
which received tumor implants, and the number
which were susceptible to the tumor implant
(tumor).
Tumors were harvested from previously im-
planted mice, cut into pieces approximately
8 mm3 in size, placed in sterile saline and used
for the propagation of the next tumor genera-
tion. For implanting, mice were anesthetized
with sodium nembutal at a dose of 1.1 pil per
gram body weight. A small incision approxi-
mately 0.5 cm long was made on the lateral
aspect of the hypogastric region. Forceps
were used to loosen the skin from the muscle
wall toward the shoulder. A previously ex-
cised piece of tumor, kept in sterile isotonic
saline, was inserted subcutaneously to approxi-
mately midway between the shoulder and hip
and the skin smoothed back in place with for-
ceps to facilitate healing of the incision.
RESULTS
The tumor maintained in the DBA/1J
strain killed the animals in 8 to 12 days,
with most of the animals succumbing on
the 10th day. In contrast, the C57BL/6J
animals were found to reject the tumor
implant and survive. Hybrid (C57BL/6J
X DBA/1J) mice either succumbed by
the 12th day or survived. After 4
months, post implant, survivors were
considered as having rejected the tumor
implant, and were terminated.
No noticeable differences in the course
of tumor development were observed be-
tween the DBA/1J strain and the hybrid
(C57BL/6J X DBA/1 J). Nor was there
any difference between male and female
in the development or rejection of the
tumor by hybrid mice.
Two hundred pure strain C57BL/6J
mice were implanted with the tumor and
none of the mice developed a tumor (fig.
1). With the Fi hybrid (C57BL/6J X
DBA/1J) generation all 200 implanted
mice developed the tumor and died within
12 days. All Fi mice had a black coat
coloring. The backcross of Fi hybrid to
the C57BL/6J strain was done with 504
mice, and 18 of these mice developed the
tumor.
Four coat colors appeared in the F2
hybrid generation: black, dark brown,
gray and light brown in a ratio of
10:8:2:1. No differences in tumor sus-
ceptibility could be correlated with coat
color. Hence coat color could not be
used as a marker in determining tumor
susceptibility, nor was any other utiliz-
able marker observed in the hybrid. The
F2 hybrid generation had 572 mice im-
planted and the tumor developed in 138
of the mice.
Generations F3 through F8, were not
implanted and were used only as pro-
genitors for the next generation, up to
the F9 generation. The F9 generation
had 583 mice implanted and the tumor
developed in 150 of the mice. Survivors
from the F9 generation were then bred to
form the Fi0 generation. In the F10 gen-
eration 509 mice were implanted and the
tumor developed in 55 of the mice.
DISCUSSION
Considering the fact that all the Fi
generation were susceptible to the tumor,
it was assumed that the histocompati-
bility for tumor development was con-
trolled by dominant genes. The prog-
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TABLE 1
Statistical treatment of sarcoma histocompatability sites in DBA/J and C57BL/6 mice.
OBSERVED
EXPECTED
OB-EX*
(OB-EX)2
EX
P
Backcross
18
15.75(^)»
2.25
0.3214
0.99>p<.95
F2
138
136 (%)•'
2
0.0294
1.00>p<.99
F9
150
138 (M)5
12
1.043
.95>p<.90
F10**
55
54.5
.5
0.0046
.99>p<.95
*()B = OBSERVED EX = EXPECTED
**The F10 expected value is derived from the possible combination available for his-
tocompatibility to be achieved. Graphic representation of the possible combina-
tions is shown in table 2.
cny from the backcross and intercross in-
dicated that the histocompatibility for
tumor development behaved as a discrete
hybrid variation. Furthermore, the tu-
mor take ratios developed with the back-
cross and the F2 generation pointed to a
5 unit inheritance factor. Chi-square p
value for the tumor take in the backcross
was 0.99>p<0.95 and for the F2 genera-
tion it was 1.00>p<0.99 (table 1).
These values are excellent for substan-
tiating the tumor take susceptibility as a
five unit inheritance factor.
Eight generations were bred in keeping
with the standard procedures to establish
a stable gene pool in a population (Green
1966). The F9 generation received tu-
mor implants and again the inheritance
of tumor susceptibility behaved as a dis-
crete function of a 5 unit inheritance
factor. Once again the 0.95>p<0.90
value for the F9 generation substantiated
the 5 unit inheritance pattern.
Additional proof was obtained by using
F9 tumor implant survivors, animals
which rejected tumor implant, as prog-
enitors for the Fio generation. If the
original hypothesis of a discrete 5 unit
inheritance factor was valid, then there
should exist in the surviving F9 indi-
viduals units of inheritance which would
represent: 4/5; 3/5; 2/5; 1/5 and 0/5 of
the total susceptibility factor. The pos-
sibilities presented here are in reality a
binomial expansion problem. A diagra-
matic representation of this binomial
with numerals representing the possible
and available chromosome (s) and the
letter X the probable distribution of the
involved histocompatibility chromo-
some (s) for tumor susceptibility is shown
in table 2. The F10 tumor take 1.00>p<
0.99 (table 1) verified that the probable
distribution of the histocompatibility
sites in F9 survivors did match and in-
deed coincide with the graphic repre-
sentation given in table 2.
TABLE 2
Matrix illustrating possible combinations
for a 5 factor distribution.
1
2
3
4
5
1
2
3
4
X
1
2
3
X
X
1
2
X
X
X
X
X
X
X
5
X
X
X
X
X
1/32
1
2
3
X
5
1
2
X
4
X
1
X
3
X
X
X
X
X
4
X
1
2
X
4
5
1
X
3
4
X
X
2
3
X
X
X
X
3
X
X
1/32
1
X
3
4
5
X
2
3
4
X
1
X
X
4
X
X
2
X
X
X
X*
2
3
4
5
1
2
X
X
5
X
2
X
4
X
1
X
X
X
X
2/32
1
X
3
X
5
X
X
3
4
X
X
2
3
X
5
1
X
X
X
5
16/32
X
X
3
4
5
X
2
X
X
5
X
2
X
4
5
X
X
3
X
5
1
X
X
4
5
X
X
X
4
5
4/32
8/32
*X marks the linkage group (s) which could
possibly be carrying the factors for tumor
histocompatibility. Numbers represent non-
histocompatible sites. The fraction indicates
the possible number of combinations for each
group in that set which would result in tumor
histocompatability being achieved.
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As mentioned earlier, there exist 15
different two-directional allelic histo-
compatibility sites between the 2 strains
of mice employed in this study. At the
maximum, however, only 8 incompati-
bilities would be involved in the take
frequency of this tumor. Although most
of the histocompatibility groups have
been assigned linkage groups (Snell and
Stimpfling 1966; Green 1971; Altman
and Dittmer 1972), several histocom-
patibility sites have not. The results
obtained in our work indicate that all the
histocompatibility sites involved belong
to no more than 5 linkage groups.
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